Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.61 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.40 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8749121 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL750126 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL4555744 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL6698113 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL7350355 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL8749149 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL794473 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL8749146 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL8749129 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH | |
| SCHEMBL2251086 | 1.00 | NOD1 (0.61) | NOD1ITGB3ITGA2BMEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220080004-A1 | Microorganisms Inhibiting the Formation of Axillary Malodor | BASF SE (DE) | 2022-03-17 | — | — | US | claimed |
| US-20200030390-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | BASF SE (DE) | 2020-01-30 | — | — | US | claimed |
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-20170224747-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | BASF SE (DE) | 2017-08-10 | — | — | US | claimed |
| US-20150216914-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | NOVOZYMES A/S (DK) | 2015-08-06 | — | — | US | claimed |
| US-20140004070-A1 | Microorganisms Inhibiting the Formation of Axillary Malodor | BASF SE (DE) | 2014-01-02 | — | — | US | claimed |
| US-20120207691-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | BASF SE (DE) | 2012-08-16 | — | — | US | claimed |
| US-20080247993-A1 | Microorganisms Inhibiting the Formation of Axillary Malodor | BASF SE (DE) | 2008-10-09 | — | — | US | claimed |
| CN-101263222-A | Microorganisms inhibiting the formation of axillary malodor | BASF SE (DE) | 2008-09-10 | — | — | CN | claimed |
| EP-1934327-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | BASF SE (DE) | 2008-06-25 | — | — | EP | claimed |
| WO-2007031300-A1 | MICROORGANISMS INHIBITING THE FORMATION OF AXILLARY MALODOR | BASF SE (DE) | 2007-03-22 | — | — | WO | claimed |
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | SYMRISE AG (DE) | 2024-07-18 | — | — | US | disclosed |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-07-04 | — | — | US | disclosed |
| EP-4387587-A1 | COMPOSITIONS | Symrise AG (DE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024110515-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | disclosed |
| US-5559092-A | HAIR GROWTH, GLUTAMINE DIPEPTIDE | CHESEBROUGH-POND'S USA CO. DIVISION OF CONOPCO, INC. (US) | 1996-09-24 | — | — | US | disclosed |
| US-5428019-A | Digestive system disorders; antitumor agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0585397-A1 | BOMBESIN ANALOGS. | MERRELL DOW PHARMA (US) | 1994-03-09 | — | — | EP | disclosed |
| EP-0571198-A1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992020707-A1 | BOMBESIN ANALOGS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | NOD1 4571/4885ITGB3 4613/4885ITGA2B 4207/4885 |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | UGCG, SGMS1, GPR119 | NOD1 252/4885ITGB3 3937/4885ITGA2B 3781/4885 |
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | ZC3HAV1, SAMHD1, ZC3HAV1L | NOD1 1264/4885ITGB3 3678/4885ITGA2B 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.